These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35742860)

  • 21. Mechanisms of action of triptolide against colorectal cancer: insights from proteomic and phosphoproteomic analyses.
    Song X; He H; Zhang Y; Fan J; Wang L
    Aging (Albany NY); 2022 Apr; 14(7):3084-3104. PubMed ID: 35366242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combining Click Chemistry-Based Proteomics With Dox-Inducible Gene Expression.
    Gebert J; Schnölzer M; Warnken U; Kopitz J
    Methods Enzymol; 2017; 585():295-327. PubMed ID: 28109436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promoter hypermethylation of LGALS4 correlates with poor prognosis in patients with urothelial carcinoma.
    Wu MM; Li CF; Lin LF; Wang AS; Pu YS; Wang HH; Mar AC; Chen CJ; Lee TC
    Oncotarget; 2017 Apr; 8(14):23787-23802. PubMed ID: 28423602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Up-regulation of type I collagen during tumorigenesis of colorectal cancer revealed by quantitative proteomic analysis.
    Zou X; Feng B; Dong T; Yan G; Tan B; Shen H; Huang A; Zhang X; Zhang M; Yang P; Zheng M; Zhang Y
    J Proteomics; 2013 Dec; 94():473-85. PubMed ID: 24332065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LYAR promotes colorectal cancer cell mobility by activating galectin-1 expression.
    Wu Y; Liu M; Li Z; Wu XB; Wang Y; Wang Y; Nie M; Huang F; Ju J; Ma C; Tan R; Zen K; Zhang CY; Fu K; Chen YG; Wang MR; Zhao Q
    Oncotarget; 2015 Oct; 6(32):32890-901. PubMed ID: 26413750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colorectal cancer proteomics, molecular characterization and biomarker discovery.
    Barderas R; Babel I; Casal JI
    Proteomics Clin Appl; 2010 Feb; 4(2):159-78. PubMed ID: 21137041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of Proteome Changes in Human Colon Cancer Induced by Cell Surface Binding of Growth-Inhibitory Human Galectin-4 Using Quantitative SILAC-Based Proteomics.
    Michalak M; Warnken U; André S; Schnölzer M; Gabius HJ; Kopitz J
    J Proteome Res; 2016 Dec; 15(12):4412-4422. PubMed ID: 27801591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deep Phospho- and Phosphotyrosine Proteomics Identified Active Kinases and Phosphorylation Networks in Colorectal Cancer Cell Lines Resistant to Cetuximab.
    Abe Y; Nagano M; Kuga T; Tada A; Isoyama J; Adachi J; Tomonaga T
    Sci Rep; 2017 Sep; 7(1):10463. PubMed ID: 28874695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative proteomic analysis exploring progression of colorectal cancer: Modulation of the serpin family.
    Peltier J; Roperch JP; Audebert S; Borg JP; Camoin L
    J Proteomics; 2016 Oct; 148():139-48. PubMed ID: 27492143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ZBTB7A functioned as an oncogene in colorectal cancer.
    Wang L; Zhang MX; Zhang MF; Tu ZW
    BMC Gastroenterol; 2020 Nov; 20(1):370. PubMed ID: 33167891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surface-bound galectin-4 regulates gene transcription and secretion of chemokines in human colorectal cancer cell lines.
    Rao US; Rao PS
    Tumour Biol; 2017 Mar; 39(3):1010428317691687. PubMed ID: 28345468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Luteolin inhibits colorectal cancer cell epithelial-to-mesenchymal transition by suppressing CREB1 expression revealed by comparative proteomics study.
    Liu Y; Lang T; Jin B; Chen F; Zhang Y; Beuerman RW; Zhou L; Zhang Z
    J Proteomics; 2017 May; 161():1-10. PubMed ID: 28391045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Knockdown of Long Non-Coding RNA XIST Inhibited Doxorubicin Resistance in Colorectal Cancer by Upregulation of miR-124 and Downregulation of SGK1.
    Zhu J; Zhang R; Yang D; Li J; Yan X; Jin K; Li W; Liu X; Zhao J; Shang W; Yu T
    Cell Physiol Biochem; 2018; 51(1):113-128. PubMed ID: 30439718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA SATB2-AS1 inhibits tumor metastasis and affects the tumor immune cell microenvironment in colorectal cancer by regulating SATB2.
    Xu M; Xu X; Pan B; Chen X; Lin K; Zeng K; Liu X; Xu T; Sun L; Qin J; He B; Pan Y; Sun H; Wang S
    Mol Cancer; 2019 Sep; 18(1):135. PubMed ID: 31492160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stathmin, a new target of PRL-3 identified by proteomic methods, plays a key role in progression and metastasis of colorectal cancer.
    Zheng P; Liu YX; Chen L; Liu XH; Xiao ZQ; Zhao L; Li GQ; Zhou J; Ding YQ; Li JM
    J Proteome Res; 2010 Oct; 9(10):4897-905. PubMed ID: 20806969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer.
    Pan Y; Tong JHM; Lung RWM; Kang W; Kwan JSH; Chak WP; Tin KY; Chung LY; Wu F; Ng SSM; Mak TWC; Yu J; Lo KW; Chan AWH; To KF
    Mol Cancer; 2018 Jul; 17(1):102. PubMed ID: 30037330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Shikonin induces colorectal carcinoma cells apoptosis and autophagy by targeting galectin-1/JNK signaling axis.
    Zhang N; Peng F; Wang Y; Yang L; Wu F; Wang X; Ye C; Han B; He G
    Int J Biol Sci; 2020; 16(1):147-161. PubMed ID: 31892852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. (Phospho)proteomic Profiling of Microsatellite Unstable CRC Cells Reveals Alterations in Nuclear Signaling and Cholesterol Metabolism Caused by Frameshift Mutation of NMD Regulator UPF3A.
    Michalak M; Katzenmaier EM; Roeckel N; Woerner SM; Fuchs V; Warnken U; Yuan YP; Bork P; Neu-Yilik G; Kulozik A; von Knebel Doeberitz M; Kloor M; Kopitz J; Gebert J
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32718059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinase-mediated cassette exchange (RMCE) - a rapidly-expanding toolbox for targeted genomic modifications.
    Turan S; Zehe C; Kuehle J; Qiao J; Bode J
    Gene; 2013 Feb; 515(1):1-27. PubMed ID: 23201421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Positive expression of basic transcription factor 3 predicts poor survival of colorectal cancer patients: possible mechanisms involved.
    Liu Q; Wu J; Lu T; Fang Z; Huang Z; Lu S; Dai C; Li M
    Cell Death Dis; 2019 Jul; 10(7):509. PubMed ID: 31263147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.